珞珈山麓

标题: 武汉大学郭德银研究组发现乙肝病毒致癌新机制 [打印本页]

作者: guozonghui888    时间: 2016-5-9 11:41
标题: 武汉大学郭德银研究组发现乙肝病毒致癌新机制
近日,Hepatology(《肝病学》)在线发表了武汉大学基础医学院病毒学国家重点实验室郭德银研究组乙肝病毒最新研究成果,论文题目为HBV e antigen and its precursors promote the progress of HCC by interacting with NUMB and decreasing p53 activity(《乙肝病毒e抗原及其前体蛋白通过结合NUMB和降低p53活性而促进肝癌发生》,第一作者为博士后刘丹,通讯作者为郭德银教授。

中国是全世界感染乙肝人数最多的国家,全世界有3.5亿左右的慢性乙肝携带者,其中约1/3在中国。目前,中国每年约有50多万人死于慢性乙型肝炎导致的肝脏损害和肝癌。该论文明确了乙肝病毒e抗原(HBeAg)与肝细胞癌发生的关系及其分子机制。
乙肝病毒HBeAg及其前体蛋白是乙肝病毒的非结构蛋白,虽然其不直接参与乙肝病毒的复制过程,但是以往研究表明,HBeAg阳性往往伴随着乙肝病毒的高复制水平;而且大量的流行病学研究也发现,相对于HBeAg阴性,在HBeAg阳性的情况下,慢性乙肝病毒感染者患肝癌的风险要提高大约3倍。然而,HBeAg是否直接促进肝细胞肿瘤发生仍然缺乏实验证据。
该研究揭示乙肝病毒HBeAg及其前体通过结合NUMB蛋白进而影响一种重要抑癌因子p53的活性进而促进肝细胞肿瘤发生。研究表明,HBeAg结合NUMB蛋白后,能促进HDM2对p53蛋白的泛素化,促进p53降解;HBeAg也能够降低p53蛋白乙酰化水平及改变其核质分布,使其更多的分布在细胞质中进而降低其转录活性。该论文解释并验证了之前关于HBeAg的流行病学研究结果,揭示HBeAg直接参与肝细胞肿瘤发生,并阐述了其促进肝癌发生的分子机制,该工作对全面了解乙肝病毒的致癌具有相对重要的理论意义,为防治该类疾病提供了新的思路和理论基础。

HBV e antigen and its precursors promote the progress of HCC by interacting with NUMB and decreasing p53 activityHepatitis B virus (HBV) infection is one of the leading causes of hepatocellular carcinoma (HCC) worldwide. Although several viral factors have been identified that may increase the risk for HCC development, the molecular mechanisms leading to the transformation of normal hepatocytes into cancer cells remain elusive. In this study, we demonstrated that the intracellular HBV e antigen (HBeAg) and its precore precursors, but not their homologous core protein, could associate with NUMB and thereby impair the stability and transcriptional activity of tumor suppressor p53. HBeAg and its precursors could disrupt p53-NUMB and HDM2-NUMB interactions and tri-complex p53-HDM2-NUMB formation, inhibit the acetylation and translocation of p53 from cytosol to the nucleus, promote HDM2-mediated ubiquitination and degradation of p53, and suppress p53-dependent apoptosis. Xenograft tumorigenicity assay showed that the expression of HBeAg and its precursors promoted carcinogenesis in a mouse model. Immunohistochemical analysis of the bioptic liver samples of HCC patients revealed that HBeAg positivity was associated with reduced transcriptional activity of p53. Taken together, the results suggest a role of intracellular HBeAg and its precursors in HCC development.
Conclusion: HBeAg and its precursors promote HDM2-mediated degradation and impair transcriptional activity of p53 via interacting with NUMB, consequently contributing to the HCC development. This article is protected by copyright. All rights reserved.

本期编辑:Biodog




欢迎光临 珞珈山麓 (http://www.luojiashan.com.cn/) Powered by Discuz! X3.1